Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers
Clinical trial NCT00920439 · COMPLETED
Trial details
- NCT number
- NCT00920439
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2009-08-03
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.